Abrdn Life Sciences Investors (HQL) Stock

Financial Services · Asset Management · Member of Other US Stocks

Abrdn Life Sciences Investors (HQL) closed at USD 17.14 on 2026-10-14, a change of +9.6 % over the past year, with a market capitalization of USD 524.23M.

Abrdn Life Sciences Investors recent closing prices

DateClose (USD)
2026-10-1417.14
2026-10-1317.26
2026-10-1218.00
2026-10-0918.15
2026-10-0817.43
2026-10-0717.56
2026-10-0617.56

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Abrdn Life Sciences Investors key figures

Previous close
USD 17.14 (2026-10-14)
1-year change
+9.6 %
Market cap
USD 524.23M
Enterprise value
USD 523.38M
P/E ratio (trailing)
2.60
P/E ratio (forward)
n/a
EPS (trailing)
6.64
EPS (forward)
n/a
PEG ratio
n/a
Price to book
0.93
Revenue growth
-60.8 %
Earnings growth
n/a
Dividend per share (trailing)
1.91
Short ratio
0.91
Employees
n/a
Analyst consensus (third-party)
none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Abrdn Life Sciences Investors and compare it with other stocks.

Analyze HQLAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Abrdn Life Sciences Investors shares.